Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Clinical effectiveness and safety comparison between direct oral anticoagulants and warfarin for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure operation intervention: a prospective observational study

Fig. 1

Enrollment flowchart of this study. Patients received one of the following anticoagulants at the discretion of the physician: (1) Rivaroxaban 15 mg once a day; (2) Dabigatran 110 mg twice daily; (3) Warfarin maintaining an international normalized ratio between 2.0 and 3.0. LAAC left atrial appendage closure, TEE trans-esophageal echocardiography, DRT device-related thrombosis

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us